BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Alam S, Mustafa G, Alam M, Ahmad N. Insulin resistance in development and progression of nonalcoholic fatty liver disease. World J Gastrointest Pathophysiol 2016; 7(2): 211-217 [PMID: 27190693 DOI: 10.4291/wjgp.v7.i2.211]
URL: https://www.wjgnet.com/2150-5330/full/v7/i2/211.htm
Number Citing Articles
1
Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, Lutgarda Bozzetto, Giovanni Annuzzi, Angela Rivellese. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk IndividualsNutrients 2017; 9(10): 1065 doi: 10.3390/nu9101065
2
Zijian Sun, Binxia Chang, Miaomiao Gao, Jiyuan Zhang, Zhengsheng Zou. IL-33-ST2 Axis in Liver Disease: Progression and ChallengeMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5314213
3
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological managementBiomedicine & Pharmacotherapy 2018; 106: 991 doi: 10.1016/j.biopha.2018.06.095
4
Sridhar Radhakrishnan, Jia-Yu Ke, Michael A Pellizzon. Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent ModelsCurrent Developments in Nutrition 2020; 4(6) doi: 10.1093/cdn/nzaa078
5
Sugeedha Jeyapal, Suryam Reddy Kona, Surekha Venkata Mullapudi, Uday Kumar Putcha, Puvaneswari Gurumurthy, Ahamed Ibrahim. Substitution of linoleic acid with α-linolenic acid or long chain n-3 polyunsaturated fatty acid prevents Western diet induced nonalcoholic steatohepatitisScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-29222-y
6
Dong-Woo Lim, Hyuck Kim, Seung-Jun Lee, Ga-Ram Yu, Jai-Eun Kim, Won-Hwan Park. Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling PathwayEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/4589810
7
Rafael García-Carretero, Roberto Holgado-Cuadrado, Óscar Barquero-Pérez. Assessment of Classification Models and Relevant Features on Nonalcoholic Steatohepatitis Using Random ForestEntropy 2021; 23(6): 763 doi: 10.3390/e23060763
8
Rajib Das, Saikat Mitra, Abu Montakim Tareq, Talha Bin Emran, Md Jamal Hossain, Ali M. Alqahtani, Yahia Alghazwani, Kuldeep Dhama, Jesus Simal-Gandara. Medicinal plants used against hepatic disorders in Bangladesh: A comprehensive reviewJournal of Ethnopharmacology 2021; : 114588 doi: 10.1016/j.jep.2021.114588
9
Qin Yi, Puyang Sun, Juan Li, Siming Kong, Jinying Tian, Xuechen Li, Yanan Yang, Peicheng Zhang, Yuying Liu, Jingyan Han, Xiaolin Zhang, Fei Ye. Rho, a Fraction From Rhodiola crenulate, Ameliorates Hepatic Steatosis in Mice ModelsFrontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00222
10
Nada Pejnovic, Ilija Jeftic, Nemanja Jovicic, Nebojsa Arsenijevic, Miodrag L Lukic. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitisWorld Journal of Gastroenterology 2016; 22(44): 9706-9717 doi: 10.3748/wjg.v22.i44.9706
11
Grietje Prins, Theerut Luangmonkong, Dorenda Oosterhuis, Henricus Mutsaers, Frank Dekker, Peter Olinga. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver SlicesNutrients 2019; 11(3): 507 doi: 10.3390/nu11030507
12
Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Ali Mottaghi-Moghaddam, Fatemeh Goldani, Majid Khazaei, Majid Ghayour-Mobarhan, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. Association between non-alcoholic fatty liver disease and colorectal cancerExpert Review of Gastroenterology & Hepatology 2019; 13(7): 633 doi: 10.1080/17474124.2019.1617696
13
Hannah E. Da Silva, Anastasia Teterina, Elena M. Comelli, Amel Taibi, Bianca M. Arendt, Sandra E. Fischer, Wendy Lou, Johane P. Allard. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistanceScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-19753-9
14
Shahinul Alam, Thupten Kelsang Lama, Golam Mustafa, Mahabubul Alam, Nooruddin Ahmad. Non-Alcoholic Fatty Liver Disease - Molecular Bases, Prevention and Treatment2018;  doi: 10.5772/intechopen.71159
15
Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial DysfunctionInternational Journal of Molecular Sciences 2019; 20(23): 5920 doi: 10.3390/ijms20235920
16
Valerio Rosato, Mario Masarone, Marcello Dallio, Alessandro Federico, Andrea Aglitti, Marcello Persico. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic SyndromeInternational Journal of Environmental Research and Public Health 2019; 16(18): 3415 doi: 10.3390/ijerph16183415
17
I Mikolasevic, L Orlic, D Stimac, I Hrstic, I Jakopcic, S Milic. Non-alcoholic fatty liver disease and colorectal cancerPostgraduate Medical Journal 2017; 93(1097): 153 doi: 10.1136/postgradmedj-2016-134383
18
Mohammad Sultan Alakhali, Sadeq Ali Al-Maweri, Hashem Motahir Al-Shamiri, Khaled Al-haddad, Esam Halboub. The potential association between periodontitis and non-alcoholic fatty liver disease: a systematic reviewClinical Oral Investigations 2018; 22(9): 2965 doi: 10.1007/s00784-018-2726-1
19
Goh Eun Chung, Jeong Yoon Yim, Donghee Kim, Min-Sun Kwak, Jong In Yang, Su Jin Chung, Sun Young Yang, Joo Sung Kim. Associations between White Blood Cell Count and the Development of Incidental Nonalcoholic Fatty Liver DiseaseGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7653689
20
Mei Guo. Cellular senescence and liver disease: Mechanisms and therapeutic strategiesBiomedicine & Pharmacotherapy 2017; 96: 1527 doi: 10.1016/j.biopha.2017.11.075
21
Zili Zhang, Zhen Yao, Yifan Chen, Lei Qian, Shuoyi Jiang, Jingyi Zhou, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng. Lipophagy and liver disease: New perspectives to better understanding and therapyBiomedicine & Pharmacotherapy 2018; 97: 339 doi: 10.1016/j.biopha.2017.07.168
22
Mayumi Nagashimada, Tsuguhito Ota. Role of vitamin E in nonalcoholic fatty liver diseaseIUBMB Life 2019; 71(4): 516 doi: 10.1002/iub.1991
23
Shahinul  Alam. Past, Present, and Future of Hepatitis B and Fatty Liver in BangladeshGastroenterology & Hepatology: Open Access 2017; 6(3) doi: 10.15406/ghoa.2017.06.00197
24
Fang-Zhou Ye, Wen-Yue Liu, Kenneth I. Zheng, Xiao-Yan Pan, Hong-Lei Ma, Xiao-Dong Wang, Yong-Ping Chen, Ming-Hua Zheng. Homeostatic model assessment of insulin resistance closely related to lobular inflammation in nonalcoholic fatty liver diseaseEuropean Journal of Gastroenterology & Hepatology 2020; 32(1): 80 doi: 10.1097/MEG.0000000000001483
25
Meng-Juan Wu, Chen Yuan, Lin-Lin Lu, Bai-Quan An, Shi-Ying Xuan, Yong-Ning Xin. Role of NCAN rs2228603 polymorphism in the incidence of nonalcoholic fatty liver disease: a case-control studyLipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0367-4
26
Xinchi Wu, Juan Xu. New Role of Hispidulin in Lipid Metabolism: PPARα ActivatorLipids 2016; 51(11): 1249 doi: 10.1007/s11745-016-4200-7
27
Helda Tutunchi, Fatemeh Naeini, Majid Mobasseri, Alireza Ostadrahimi. Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional studyClinical Nutrition ESPEN 2021; 44: 483 doi: 10.1016/j.clnesp.2021.04.025
28
Shahinul Alam, Shah Mohammad Fahim, Muhammad Abdul Baker Chowdhury, Md. Zakiul Hassan, Golam Azam, Golam Mustafa, Mainul Ahsan, Nooruddin Ahmad. Prevalence and risk factors of non-alcoholic fatty liver disease in BangladeshJGH Open 2018; 2(2): 39 doi: 10.1002/jgh3.12044
29
Rafael Garcia-Carretero, Luis Vigil-Medina, Oscar Barquero-Perez, Javier Ramos-Lopez. Relevant Features in Nonalcoholic Steatohepatitis Determined Using Machine Learning for Feature SelectionMetabolic Syndrome and Related Disorders 2019; 17(9): 444 doi: 10.1089/met.2019.0052
30
Catherine Yzydorczyk, Na Li, Eve Rigal, Hassib Chehade, Dolores Mosig, Jean Baptiste Armengaud, Thibaud. Rolle, Anithan Krishnasamy, Eulalia Orozco, Benazir Siddeek, Christian Juvet, Catherine Vergely, Umberto Simeoni. Calorie Restriction in Adulthood Reduces Hepatic Disorders Induced by Transient Postnatal Overfeeding in MiceNutrients 2019; 11(11): 2796 doi: 10.3390/nu11112796
31
Ian James Martins. Nonalcoholic Fatty Liver Disease - An Update2019;  doi: 10.5772/intechopen.81297
32
Noha El Nakeeb, Shereen A Saleh, Yasmine M Massoud, Ahmed Hussein, Rana Hamed. Serum ferritin as a non-invasive marker in the prediction of hepatic fibrosis among Egyptian patients with non-alcoholic fatty liver diseaseJGH Open 2017; 1(3): 112 doi: 10.1002/jgh3.12019
33
Su Wang, Xiafei Hong, Zhigang Tu, Guoyue Yuan. Angiopoietin-like protein 8: An attractive biomarker for the evaluation of subjects with insulin resistance and related disordersDiabetes Research and Clinical Practice 2017; 133: 168 doi: 10.1016/j.diabres.2017.08.025
34
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in miceBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
35
Min-Yu Chung, Ji-Hye Song, Jinhyuk Lee, Eun Ju Shin, Jae Ho Park, Seung-Hyun Lee, Jin-Taek Hwang, Hyo-Kyoung Choi. Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro modelMolecular Metabolism 2019; 19: 34 doi: 10.1016/j.molmet.2018.11.001
36
Jing Xu, Liangqin Gao, Huiqing Liang, Shaoliang Zhang, Penghua Lai, Shaodong Chen. Evidence for the anti-NAFLD effectiveness of chlorogenic acid as a HAT inhibitor using in vivo experiments supported by virtual molecular dockingPhytomedicine Plus 2021; 1(4): 100055 doi: 10.1016/j.phyplu.2021.100055
37
Xiao-lin Zhang, Ya-nan Wang, Lu-yao Ma, Zhong-sheng Liu, Fei Ye, Jian-hong Yang. Uncarboxylated osteocalcin ameliorates hepatic glucose and lipid metabolism in KKAy mice via activating insulin signaling pathwayActa Pharmacologica Sinica 2020; 41(3): 383 doi: 10.1038/s41401-019-0311-z
38
Amr Ali El-Sehrawy, Omnia State, Rasha Rizk Elzehery, Ahmed Salem Mohamed. Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic SyndromeHormone and Metabolic Research 2021; 53(02): 100 doi: 10.1055/a-1341-9710
39
Pierre Poinsot, Sophie Collardeau Frachon, Lioara Restier, André Sérusclat, Mathilde Di Filippo, Sybil Charrière, Philippe Moulin, Alain Lachaux, Noel Peretti. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease—four new pediatric casesJournal of Clinical Lipidology 2017; 11(1): 167 doi: 10.1016/j.jacl.2016.11.008
40
Xuan Du, Can Cai, Jialing Yao, Youping Zhou, Huihong Yu, Wei Shen. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLDBiochemical and Biophysical Research Communications 2017; 483(1): 409 doi: 10.1016/j.bbrc.2016.12.129
41
Feng Qiao, Kaiyu Fu, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Yang Xia, Xue Bao, Yeqing Gu, Hongbin Shi, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Kaijun Niu. The association between missing teeth and non‐alcoholic fatty liver disease in adultsJournal of Clinical Periodontology 2018; 45(8): 941 doi: 10.1111/jcpe.12929
42
Margaryta Khomenko. CYTOKERATIN-18 AS A MARKER OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OBESE ADOLESCENTSEUREKA: Health Sciences 2020; 5: 28 doi: 10.21303/2504-5679.2020.001415